[Surveillance after prostate cancer radiotherapy]

Cancer Radiother. 2011 Oct;15(6-7):540-5. doi: 10.1016/j.canrad.2011.05.005. Epub 2011 Jul 26.
[Article in French]

Abstract

Follow-up after prostate cancer radiotherapy aims at detecting local or metastatic relapse, as well as long-term toxicity, requiring adapted treatments. Several scientific societies have published guidelines including clinical, biological and imaging recommendations. More data suggest a role for aggressive salvage therapy in case of local failure following radiotherapy. An adequate follow-up is required for the sake of patients' safety, i.e. to a posteriori validate dose constraints and radiation technique in each radiotherapy department.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Adenocarcinoma / blood
  • Adenocarcinoma / radiotherapy*
  • Adenocarcinoma / surgery
  • Aftercare*
  • Androgens
  • Brachytherapy / adverse effects
  • Combined Modality Therapy
  • Erectile Dysfunction / etiology
  • Follow-Up Studies
  • Hormone Antagonists / therapeutic use
  • Humans
  • Intestines / radiation effects
  • Male
  • Neoplasms, Hormone-Dependent / drug therapy
  • Neoplasms, Hormone-Dependent / radiotherapy
  • Neoplasms, Hormone-Dependent / surgery
  • Neoplasms, Radiation-Induced / diagnosis
  • Neoplasms, Radiation-Induced / etiology
  • Neoplasms, Second Primary / diagnosis
  • Neoplasms, Second Primary / etiology
  • Orchiectomy
  • Organs at Risk
  • Palpation
  • Population Surveillance*
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / radiotherapy*
  • Prostatic Neoplasms / surgery
  • Radiation Injuries / etiology
  • Radiation Injuries / therapy
  • Radiotherapy / adverse effects
  • Recurrence
  • Salvage Therapy
  • Urinary Tract / radiation effects

Substances

  • Androgens
  • Hormone Antagonists
  • Prostate-Specific Antigen